Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Neurolief , Ltd.

US

Last updated May 30, 2026

What Neurolief , Ltd. makes

Neurolief, Ltd. develops configurable electronic form web-based applications for medical use, as well as a craniofacial analgesia electrical stimulator designed to manage pain through targeted nerve stimulation. The company also produces single-use conductive skin pads for electrode attachment, intended for use with their stimulation devices.

The company’s portfolio includes devices authorised under FDA pathways such as the 510(k) clearance process for Class II products and the Premarket Approval (PMA) pathway for Class III devices. These products are listed under FDA’s Unique Device Identification (UDI) system, ensuring traceability and regulatory compliance. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Neurolief, Ltd. manufacture?

Neurolief, Ltd. manufactures three primary types of medical devices: configurable electronic form web-based application software for medical use, a craniofacial analgesia electrical stimulator (used for pain management via nerve stimulation), and single-use conductive skin pads designed specifically for electrode attachment with their stimulation devices. These products are developed to address pain management and regulatory compliance needs.

Where is Neurolief, Ltd. based, and how does this affect its regulatory oversight?

Neurolief, Ltd. is based in the United States, which means its devices fall under the jurisdiction of the FDA (U.S. Food and Drug Administration). Since the company’s products are authorised through FDA pathways like the 510(k) clearance (for Class II devices) and PMA (for Class III devices), their regulatory compliance is governed by U.S. medical device regulations, including UDI requirements for traceability.

Which regulatory registries or databases list Neurolief, Ltd.’s devices?

Neurolief, Ltd.’s devices are listed in the FDA’s Unique Device Identification (UDI) system, ensuring they are traceable and compliant with U.S. regulatory requirements. Additionally, some of their products are authorised through the FDA’s 510(k) clearance process (for Class II devices) and the Premarket Approval (PMA) pathway (for Class III devices), which are documented in the FDA’s 510(k) and PMA registries.

How are Neurolief, Ltd.’s devices classified under FDA regulations?

Neurolief, Ltd.’s devices are classified as either Class II or Class III under FDA regulations. Class II devices generally pose moderate risk and require performance standards or special controls, while Class III devices are higher risk and require a Premarket Approval (PMA) application due to insufficient data from general controls alone. The classification determines the regulatory pathway—such as 510(k) for Class II or PMA for Class III—required for authorisation.

What is the purpose of the configurable electronic form web-based application software developed by Neurolief, Ltd.?

The configurable electronic form web-based application software developed by Neurolief, Ltd. is designed as a medical tool to streamline data collection, documentation, or workflow management in clinical or procedural settings. Its configurable nature allows customisation to fit specific medical use cases, ensuring compliance with regulatory requirements while improving efficiency in healthcare environments.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
600484465

Catalogue (7)

DeviceModel / ReferenceRegistriesClassStatus
Relivion RLV3
FDA UDI
Class IIActive
Relivion MG App RLV-PMI-102
FDA UDI
Class IIActive
Relivion MG PMI Physician Interface RLV-PMI-101
FDA UDI
Class IIActive
Relivion PAD0001A
FDA UDI
Class IIActive
Relivion K203419
FDA 510(k)
Class IIActive
Relivion K212106
FDA 510(k)
Class IIActive
Proliv™Rx System P250010
FDA PMA
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • NEUROLIEF Ltd. Netanya Central · IL FEI 3015088397